<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03136887</url>
  </required_header>
  <id_info>
    <org_study_id>16-4049-06</org_study_id>
    <secondary_id>U1111-1191-7751</secondary_id>
    <nct_id>NCT03136887</nct_id>
  </id_info>
  <brief_title>JOURNEY II XR Safety and Effectiveness PMCF</brief_title>
  <official_title>A Prospective, Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the JOURNEY™ II XR Total Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to demonstrate the safety and performance of the JOURNEY II XR total
      knee system by evaluating implant survival rates at 10 years using Kaplan-Meier analysis. All
      participants will be implanted with the JOURNEY II XR total knee system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee arthroplasty (TKA) is considered the most beneficial and cost-effective treatment
      for end-stage knee arthritis and is the most frequently performed joint replacement surgery.
      TKA is also indicated for earlier osteoarthritis (OA) interventions, such as osteotomy or
      unicompartmental replacement, when additional treatment is warranted. One device option
      available once the decision is made to perform TKA is the JOURNEY II XR Total Knee System.
      The JOURNEY II XR Total Knee System is designed to be a more &quot;natural feeling&quot; total knee
      replacement. The goal of the JOURNEY II XR is to enable a higher level of function after
      total knee replacement by relieving pain and restoring the ability to participate in active
      lifestyles. The main aim of this study is to generate long-term safety and performance data
      for the JOURNEY™ II XR Total Knee System. Effectiveness information such as short- and
      long-term function, subject satisfaction, and quality of life will also be measured.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 28, 2017</start_date>
  <completion_date type="Anticipated">April 2029</completion_date>
  <primary_completion_date type="Anticipated">April 2029</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant survival rate</measure>
    <time_frame>10 years</time_frame>
    <description>Did knee survive with no revision through 10 years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee function</measure>
    <time_frame>10 years</time_frame>
    <description>Lateral Step-Up Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - EQ-5D - 3L</measure>
    <time_frame>10 years</time_frame>
    <description>Patient Reported Outcomes using EuroQol Five Dimensions Questionnaire (EQ-5D - 3L) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - FJS</measure>
    <time_frame>10 years</time_frame>
    <description>Patient Reported Outcomes using Forgotten Joint Score (FJS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - KOOS</measure>
    <time_frame>10 years</time_frame>
    <description>Patient Reported Outcomes using Knee Injury and Osteoarthritic Outcome Scores (KOOS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - ABC scale</measure>
    <time_frame>10 years</time_frame>
    <description>Patient Reported Outcomes using Activities-specific Balance Confidence (ABC) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - SAPSS</measure>
    <time_frame>10 years</time_frame>
    <description>Patient Reported Outcomes using Self-Administered Patient Satisfaction Score (SAPSS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiotherapy (PT) utilization - No. of visits</measure>
    <time_frame>6 Months Post-operatively</time_frame>
    <description>Number of PT visits required up to 6 months after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiotherapy (PT) utilization - Period of visits</measure>
    <time_frame>6 Months Post-operatively</time_frame>
    <description>Time period during which PT appointments are required up to 6 months after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic outcomes</measure>
    <time_frame>10 years</time_frame>
    <description>X-rays of index joint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events (AEs)</measure>
    <time_frame>10 years</time_frame>
    <description>All AEs will be collected and reported</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee</condition>
  <condition>Unilateral Post-Traumatic Osteoarthritis of Knee</condition>
  <condition>Knee Osteoarthritis</condition>
  <condition>Degenerative Arthritis Peripheral Joint</condition>
  <condition>Failed Osteotomies</condition>
  <condition>Failed Unicompartmental Replacement</condition>
  <arm_group>
    <arm_group_label>JOURNEY II XR TKA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This is a single arm study, all subjects will receive JOURNEY II XR TKA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>JOURNEY II XR Total Knee System</intervention_name>
    <description>JOURNEY II XR Total Knee System</description>
    <arm_group_label>JOURNEY II XR TKA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. require TKA due to rheumatoid arthritis, post-traumatic arthritis, osteoarthritis, or
             degenerative arthritis, failed osteotomies, or failed unicompartmental replacement

          2. have all cruciate and collateral ligaments intact in the index joint

          3. adult patients that in the judgement of the Investigator are skeletally mature

          4. be willing and able to participate in required follow-up visits at the investigational
             site and to complete study procedures and questionnaires

          5. consent to participate in the study by signing the IRB/EC approved informed consent
             form

        Exclusion Criteria:

          1. have any of the following conditions in the index joint:

               -  Intra-articular corticosteroid therapy (or any other intra-articular therapy) in
                  the study knee within 3 months of study enrollment

               -  Significant varus or valgus deformities (&gt;15º)

               -  Incomplete or insufficient tissue surrounding the knee

               -  Collateral ligament insufficiency

               -  Inadequate bone stock to support the device (e.g., severe
                  osteopenia/osteoporosis) or will require use of femoral and tibial stems

               -  Does not require patella resurfacing

               -  History of prior TKA

          2. have any of the following conditions in the contralateral joint:

               -  a previous TKA as a revision for a failed total or unicondylar knee arthroplasty

               -  a primary TKA or unicondylar knee arthroplasty that is not fully healed and
                  well-functioning as determined by the Investigator

          3. have any of the following conditions of the hip:

               -  a previous contralateral or ipsilateral revision hip arthroplasty

               -  ipsilateral hip arthritis resulting in flexion contracture

               -  previously received an ipsilateral or contralateral primary total hip
                  arthroplasty or hip resurfacing arthroplasty that is not fully healed and
                  well-functioning as determined by the Investigator

          4. have a diagnosis of an immunosuppressive disorder

          5. have an active infection, treated or untreated, systemic or at the site of the planned
             surgery

          6. have conditions that may interfere with the TKA survival or outcome, including but not
             limited to: Paget's disease, Charcot's disease, vascular insufficiency, muscular
             atrophy, uncontrolled diabetes, renal insufficiency or neuromuscular disease

          7. have a BMI &gt; 40

          8. be facing current or impending incarceration

          9. have a known allergy to study device or one or more of its components

         10. be pregnant or have plans to become pregnant during the course of the study

         11. have, in the opinion of the Investigator, an emotional or neurological condition that
             would pre-empt their ability or willingness to participate in the study including
             mental illness, mental retardation, drug or alcohol abuse

         12. be enrolled in another drug, biologic, or device study within 30 days of screening

         13. be known to be at risk for lost to follow-up or failure to return for scheduled visits

         14. during the surgery, have a cruciate ligament tibial bone island that is secured with
             any fixative device (e.g. screw, plate, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tad Gerlinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Orthopaedics at Rush</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tammy Footer</last_name>
    <phone>817-916-1416</phone>
    <email>tammy.footer@smith-nephew.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chris Cain</last_name>
    <phone>978.749.1382</phone>
    <email>chris.cain@smith-nephew.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda University Dept. of Orthopaedic Surgery</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Clarke</last_name>
      <phone>909-558-5592</phone>
      <email>eaclarke@llu.edu</email>
    </contact>
    <investigator>
      <last_name>Nirav Amin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Cross Orthopedic Institute</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33334</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shanell Disla</last_name>
      <phone>954-229-8682</phone>
      <email>shanell.disla@holy-cross.com</email>
    </contact>
    <investigator>
      <last_name>Martin Roche, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Castle Orthopaedics &amp; Sports Medicine, S.C.</name>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rob Johnson, PA</last_name>
      <phone>630-978-3800</phone>
      <email>robert.johnson@rushcopley.com</email>
    </contact>
    <investigator>
      <last_name>Mark Schinsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Orthopaedics at Rush</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine (Kate) Braunsky, RN</last_name>
      <phone>312-432-2429</phone>
      <email>katherine.braunsky@rushortho.com</email>
    </contact>
    <investigator>
      <last_name>Tad Gerlinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anne Arundel Medical Center</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcia Fowler</last_name>
      <phone>443-481-5757</phone>
      <email>mfowler3@aahs.org</email>
    </contact>
    <investigator>
      <last_name>James MacDonald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reno Orthopaedic Center</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gayle Blevins, CCRC</last_name>
      <phone>775-788-5190</phone>
    </contact>
    <investigator>
      <last_name>Mihael Ries, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jackson Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercer Bucks Orthopaedics</name>
      <address>
        <city>Hamilton</city>
        <state>New Jersey</state>
        <zip>08691</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>NYU Hospital for Joint Diseases / NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariel Aponte, CCRC</last_name>
      <phone>212-460-0176</phone>
      <email>ariel.aponte@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Rebekah Dixon, UK</last_name>
      <phone>212-598-2311</phone>
      <email>Rebekah.Dixon@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ran Schwarzkopf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivan F Madrid, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Hip &amp; Knee Replacement</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matt Heller</last_name>
      <phone>551-206-2296</phone>
      <email>mh3818@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>tad Gerlinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Lindner Research Center at the Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Foglesong</last_name>
      <phone>513-585-1699</phone>
      <email>sandra.foglesong@thechristhospital.com</email>
    </contact>
    <investigator>
      <last_name>Michael Swank, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adam Rosencrans</last_name>
      <phone>503-494-2345</phone>
      <email>rosencad@ohs.edu</email>
    </contact>
    <investigator>
      <last_name>Tom Huff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Regional Medical Center Everett</name>
      <address>
        <city>Everett</city>
        <state>Washington</state>
        <zip>98201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean Rocco, UK</last_name>
      <phone>425-261-3499</phone>
      <email>Dean.Rocco@providence.org</email>
    </contact>
    <investigator>
      <last_name>William (Bill) Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Singh JA, Lewallen DG. Time trends in the characteristics of patients undergoing primary total knee arthroplasty. Arthritis Care Res (Hoboken). 2014 Jun;66(6):897-906. doi: 10.1002/acr.22233.</citation>
    <PMID>24249702</PMID>
  </reference>
  <reference>
    <citation>Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, Beard DJ. Knee replacement. Lancet. 2012 Apr 7;379(9823):1331-40. doi: 10.1016/S0140-6736(11)60752-6. Epub 2012 Mar 6. Review.</citation>
    <PMID>22398175</PMID>
  </reference>
  <reference>
    <citation>Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000. Epub 2007 Aug 27. Review.</citation>
    <PMID>17719803</PMID>
  </reference>
  <reference>
    <citation>Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000 Sep;43(9):1905-15.</citation>
    <PMID>11014340</PMID>
  </reference>
  <reference>
    <citation>Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003 Dec;62(12):1145-55. Review.</citation>
    <PMID>14644851</PMID>
  </reference>
  <reference>
    <citation>NIH Consensus Panel. NIH Consensus Statement on total knee replacement December 8-10, 2003. J Bone Joint Surg Am. 2004 Jun;86-A(6):1328-35. Review.</citation>
    <PMID>15173310</PMID>
  </reference>
  <reference>
    <citation>Dowsey MM, Gunn J, Choong PF. Selecting those to refer for joint replacement: who will likely benefit and who will not? Best Pract Res Clin Rheumatol. 2014 Feb;28(1):157-71. doi: 10.1016/j.berh.2014.01.005. Review.</citation>
    <PMID>24792950</PMID>
  </reference>
  <reference>
    <citation>Gidwani S, Fairbank A. The orthopaedic approach to managing osteoarthritis of the knee. BMJ. 2004 Nov 20;329(7476):1220-4. Review.</citation>
    <PMID>15550426</PMID>
  </reference>
  <reference>
    <citation>Parvizi J, Hanssen AD, Spangehl MJ. Total knee arthroplasty following proximal tibial osteotomy: risk factors for failure. J Bone Joint Surg Am. 2004 Mar;86-A(3):474-9.</citation>
    <PMID>14996871</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Rheumatoid Vasculitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

